News

Spring TBIG Schedule

Please find the Spring TBIG Schedule Below. All meetings will be held on Thursdays from 1-2pm in Crosstown Center (801 Mass Ave.) Conference Room 386 (3rd Floor) as well as on Zoom at the following meeting ID:

Join via Zoom

https://bostonmedicalcenter.zoom.us/j/93318884767?pwd=KzRNQjNXak5jMVlzdEdlNUEvckVyQT09

Meeting ID: 933 1888 4767 |   Passcode: tbig

Schedule/Presenters:

Researchers Find Potential Way to Tweak Immune System to Help It Fight Tuberculosis

TB is the world’s second-deadliest infectious disease, behind COVID-19. A new BU-led study shows how to turn TB-susceptible immune cells into TB-resistant ones.

Read more here: https://www.bu.edu/articles/2023/researchers-find-potential-way-to-help-immune-system-fight-tuberculosis/?utm_campaign=the_brink&utm_source=email_20231011_full_b&utm_medium=2_must_read_2&utm_content=research_infectiousdiseases

Estimated costs for patients with tuberculosis in LMICs (Portnoy et al., 2023)

Check out the latest study by Portnoy et al. (2023) on the economic costs of tuberculosis treatment in low- and middle-income countries. The study delves into the often-overlooked financial burdens faced by patients, even in the presence of ostensibly free treatment. By synthesizing data from 22 national surveys conducted between 2015 and 2022, the authors estimated per-patient costs across various categories—direct medical, direct non-medical, and indirect. Notably, the findings revealed that mean direct medical costs stood at US$211, while direct non-medical and indirect costs were estimated at $512 and $530 per episode of tuberculosis, respectively. The publication underscores the urgency of addressing these economic challenges to enhance accessibility to tuberculosis diagnosis and treatment, aligning with the objectives outlined in the WHO's End TB Strategy. 

Read more about this exciting work here: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00369-8/fulltext

Portnoy et al. (2023) reveals economic potential of novel TB vaccines in low- and middle-income countries

Discover the potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries through a recently published modeling study in PLOS Medicine. In this study, Assistant Professor Allison Portnoy uncovers significant potential for these vaccines to drive substantial GDP gains, fostering economic development in LMICs.

Read more about this exciting work here: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004252

Providence/Boston Center for AIDS Research Awarded $9.2 Million NIH Renewal

The Providence/Boston Center for AIDS Research (Prov/Bos CFAR) has received a five-year $9.2 million award from the National Institutes of Health (NIH) to further its work promoting multi-disciplinary clinical, behavioral, translation, and basic science HIV research. Their research is particularly focused on marginalized populations including men who have sex with men (MSM), people who use substances, justice-involved persons, women, gender minorities, and at-risk youth. To achieve this goal, the Prov/Bos CFAR is committed to fostering emerging HIV investigators, expanding collaborative research, and promoting outreach dissemination and education domestically and within other resource-limited settings.

Portnoy et al. (2023) shows promise of novel TB vaccines for health equity in low-income and middle-income countries

Introducing a recently published paper in BMJ Global Health  by Assistant Professor Allison Portnoy titled "The Potential Impact of Novel Tuberculosis Vaccines on Health Equity and Financial Protection in Low-Income and Middle-Income Countries."

The study reveals that these vaccines can significantly reduce financial vulnerability and improve health outcomes, particularly for lower-income groups.

Read more about the groundbreaking findings and recommendations here: https://gh.bmj.com/content/8/7/e012466.full

 

Fall TBIG Schedule

Please find the Fall TBIG Schedule Below. All meetings will be held on Thursdays from 1-2pm in Crosstown Center (801 Mass Ave.) Conference Room 2020 (2nd Floor) as well as on Zoom at the following meeting ID:

Join Zoom Meeting

https://us06web.zoom.us/j/91665772569?pwd=NXFsTjBTN0szaEtFTXRHLzlBVk15QT09

Meeting ID: 916 6577 2569

Passcode: tbig

Schedule/Presenters: